News & Updates

Lung cancer death rates drop with CT screening

22 Apr 2020 by

Volume-based, low-dose computed tomography (CT) screening reduced lung cancer mortality rates in former and current smokers, the Dutch-Belgian NELSON* trial has shown.

Lung cancer death rates drop with CT screening

22 Apr 2020

PSMA PET-CT superior to CT plus bone scan in high-risk prostate cancer

21 Apr 2020 by

Prostate-specific membrane antigen (PSMA) PET-CT offers superior accuracy in identifying pelvic nodal or distant-metastatic disease in men with high-risk prostate cancer and may be a suitable replacement for conventional imaging with CT combined with bone scan, according to results of the proPSMA study.

PSMA PET-CT superior to CT plus bone scan in high-risk prostate cancer

21 Apr 2020

Pembrolizumab improves pCR in early triple-negative breast cancer

21 Apr 2020 by

The addition of the anti-PD-1* monoclonal antibody pembrolizumab to platinum-based neoadjuvant chemotherapy (CT) led to a significant increase in the proportion of women with early triple-negative breast cancer (TNBC) who had a pathological complete response (pCR), the phase III KEYNOTE-522 trial has shown.

Pembrolizumab improves pCR in early triple-negative breast cancer

21 Apr 2020

News & Updates

Filter by Specialty:

Specialty:

Lung cancer death rates drop with CT screening

Lung cancer death rates drop with CT screening

PSMA PET-CT superior to CT plus bone scan in high-risk prostate cancer

PSMA PET-CT superior to CT plus bone scan in high-risk prostate cancer

Pembrolizumab improves pCR in early triple-negative breast cancer

Pembrolizumab improves pCR in early triple-negative breast cancer